Aspirin prevents NF-κB activation and CDX2 expression stimulated by acid and bile salts in oesophageal squamous cells of patients with Barrett's oesophagus.
about
Aspirin prevents NF-κB activation and CDX2 expression stimulated by acid and bile salts in oesophageal squamous cells of patients with Barrett's oesophagus.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Aspirin prevents NF-κB activat ...... nts with Barrett's oesophagus.
@en
Aspirin prevents NF-κB activat ...... nts with Barrett's oesophagus.
@nl
type
label
Aspirin prevents NF-κB activat ...... nts with Barrett's oesophagus.
@en
Aspirin prevents NF-κB activat ...... nts with Barrett's oesophagus.
@nl
prefLabel
Aspirin prevents NF-κB activat ...... nts with Barrett's oesophagus.
@en
Aspirin prevents NF-κB activat ...... nts with Barrett's oesophagus.
@nl
P2093
P2860
P1433
P1476
Aspirin prevents NF-κB activat ...... ents with Barrett's oesophagus
@en
P2093
Chunhua Yu
David H Wang
Edaire Cheng
John P Lynch
Kerry B Dunbar
Qiuyang Zhang
Robert S Bresalier
Stuart J Spechler
Thai H Pham
P2860
P304
P356
10.1136/GUTJNL-2016-313584
P407
P577
2017-04-25T00:00:00Z